about
Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation.The hypertensiogenetic steroid 19-nor-progesterone does not influence cortisol inactivation by 11beta-hydroxysteroid dehydrogenase type 2.Renal PPARγ mRNA expression increases with impairment of renal function in patients with chronic kidney disease.IGF-1, IGFBP-3 and ALS in adult patients with chronic kidney disease.The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease.Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-β₁ in patients with chronic kidney disease.Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.
P50
Q33220849-35E1FA99-EF80-4F0C-8EBC-BE0B19B67B90Q37331941-DF8EFF1A-B593-441D-8D62-AB1BBC7165C3Q39790378-E19CE4A5-57A7-4001-8809-D9078137325FQ42840206-11945816-497F-4D83-ACCE-75284AAC70BBQ43236998-FC98C197-2612-48B7-894B-3A7C477386B4Q46558237-BBEB03CD-6896-4F40-AED6-DCB499181256Q46689565-50F1AF1E-0321-4E17-9B04-069D4CE582DCQ52894668-449B13F7-3164-4C9C-84D1-59F68DAA7B7AQ52935488-16A4469D-AAAB-4504-A8AD-932815B04272
P50
description
Nephrologist and researcher
@en
name
Julia Lepenies
@en
Julia Lepenies
@nl
type
label
Julia Lepenies
@en
Julia Lepenies
@nl
prefLabel
Julia Lepenies
@en
Julia Lepenies
@nl
P106
P1153
6602242100